Dewan Chowdhury - Nemaura Medical Chairman of the Board and Presidentident, CEO
Chairman
Dr. Dewan Fazlul Hoque Chowdhury is Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer of the Company. Since January 20, 2009. He is in charge of research and development of our core technologies, product development, innovation and commercialization. He also coordinates and oversees legal compliance development of the company mission policy and planning. Prior to establishing the Company, Dr. Chowdhury was the founder and CEO of Microneedle Technologies and Nemaura Pharma Limited where he played a pivotal role in the development, manufacture and launch of a microneedle device used in skin clinics, which is also currently being evaluated for skin cancer drug delivery. Dr. Chowdhury was responsible for negotiating licensing deals for a transdermal patch to treat Alzheimer disease. Additionally he was involved in negotiations for outlicensing patches to treat Parkinson and Hypertension, and inlicensing complementary technologies since 2019.
| Age | 51 |
| Tenure | 6 years |
| Phone | 646 416 7912 |
| Web | https://nemauramedical.com |
Dewan Chowdhury Latest Insider Activity
Tracking and analyzing the buying and selling activities of Dewan Chowdhury against Nemaura Medical pink sheet is an integral part of due diligence when investing in Nemaura Medical. Dewan Chowdhury insider activity provides valuable insight into whether Nemaura Medical is net buyers or sellers over its current business cycle. Note, Nemaura Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Nemaura Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Dewan Chowdhury over a year ago Acquisition or disposition of Nemaura Medical securities by Dewan Chowdhury |
Nemaura Medical Management Efficiency
The company has return on total asset (ROA) of (0.4928) % which means that it has lost $0.4928 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.2444) %, meaning that it created substantial loss on money invested by shareholders. Nemaura Medical's management efficiency ratios could be used to measure how well Nemaura Medical manages its routine affairs as well as how well it operates its assets and liabilities.Nemaura Medical currently holds 20.03 M in liabilities. Nemaura Medical has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nemaura Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Nemaura Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nemaura Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nemaura to invest in growth at high rates of return. When we think about Nemaura Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| Paul DiPerna | Modular Medical | 66 | |
| James Mackin | Artivion | 58 | |
Management Performance
| Return On Equity | -7.24 | ||||
| Return On Asset | -0.49 |
Nemaura Medical Leadership Team
Elected by the shareholders, the Nemaura Medical's board of directors comprises two types of representatives: Nemaura Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nemaura. The board's role is to monitor Nemaura Medical's management team and ensure that shareholders' interests are well served. Nemaura Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nemaura Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jay Warner, Head Operations | ||
| Thomas Mortensen, Head Marketing | ||
| Dewan Chowdhury, Chairman of the Board and Presidentident, CEO | ||
| Arash Ghadar, Chief Officer | ||
| Samantha Sanders, Global Programs | ||
| Bashir Timol, Chief Director |
Nemaura Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nemaura Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.24 | ||||
| Return On Asset | -0.49 | ||||
| Current Valuation | 22.58 M | ||||
| Shares Outstanding | 28.9 M | ||||
| Shares Owned By Insiders | 48.30 % | ||||
| Shares Owned By Institutions | 7.70 % | ||||
| Number Of Shares Shorted | 52.57 K | ||||
| Price To Earning | (707.14) X | ||||
| Price To Book | 122.56 X | ||||
| Price To Sales | 804.62 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |